This is the authors' abstract. We don't add key points for this paper.
Nipple-sparing mastectomy (NSM) has gained popularity because of its improved aesthetics and oncological outcomes. This study focuses on staged mastopexy as a technique for optimizing aesthetics in patients with a history of NSM and implant-based reconstruction. The authors aim to evaluate staged mastopexy as a technique to address complications such as implant and nipple–areolar complex malposition, rippling, and ptotic skin envelope, with a focus on patient selection, surgical technique, and patient-reported outcomes. The authors performed a retrospective analysis on a series of 5 patients who underwent NSM and immediate implant-based reconstruction with staged mastopexy by a single surgeon between 2020 and 2023. Descriptive analyses and t-tests were used. Significance was defined as P ≤ .05. The cohort consisted of 5 patients (10 breasts) with a median age of 43 ± 6.5 years, and average BMI was 22.9 ± 2.2 kg/m2. The mean interval from mastectomy to mastopexy was 431.5 ± 232.1 days. Notably, no cases of partial or total nipple necrosis were observed. BREAST-Q surveys revealed significantly higher satisfaction scores for breasts (74 ± 19.9, P = .01) compared with normative values, with an 80% response rate. Staged mastopexy demonstrates a safe and reproducible technique for correcting nipple and implant malposition following NSM and implant-based reconstruction.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Campbell et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: